Shareholders' letter | Year end 2021 updates

Archive: a copy of the email letter sent to Rightangled's shareholders on 25 December 2021. Retained as a historical record. Figures and plans described reflect the position at that time.

"Dear Investors,

Merry Christmas! I hope this email finds you in good health.

Welcome to your end-of-year (2021) newsletter.

The second half of 2021 has been very promising, transitioning from being one of the busiest times for Rightangled so far into what seems to be a new chapter in Rightangled's scale-up journey.

The past year has made plenty of room for growth and new opportunities, which we are excited to announce.

• Turnover of over £17M in 2021 with an operating profit of nearly £4M
• Investing in business assets:
  • Acquisition of a commercial building at 32 Galena Road, Hammersmith, London. Our new HQ consists of three floors spanning 4,178 sq ft.
  • Acquisition of the domain name rightangled.com — the transition from our current '.co' suffix to '.com' will provide easier access to international markets and solidify the company's market positioning.
• Dispatched over half a million tests, reaching our highest selling point in July and August last summer.
• We quadrupled the number of customers and B2B clients, delivering across the entire United Kingdom and opening a same-day courier service in London (within the M25).
• We are now transitioning back into increasing demand for our blood and DNA tests, aiming to deliver nationwide through cross-sales and up-sales, managed directly from the user portal.
• We are working on gaining more exposure internationally, aiming to launch our services in the US as well as other parts of Europe.

Finally, we are proud to announce that we are currently working on a project to deliver personalised medicine to the masses. We are now opening an online pharmacy alongside a mobile app, which we aim to launch in the new year.

We have a lot more to cover, so please stay tuned to find out more about our future projects.

We greatly appreciate your support, early backers.

Yours sincerely,

Abdullah
CEO of Rightangled"

About Rightangled today

Rightangled is a UK-registered online pharmacy offering prescription treatments, home blood tests and DNA tests to patients in the UK. All results are reviewed by our clinical team, which includes GPhC-registered independent prescribers, with medical oversight from our doctor, Dr Abdullah.

If you are outside the UK, our sister service Medetone serves patients in other markets.

This page is retained as a historical record and does not describe current services or performance.